Aciclovir Versus Placebo for HSV-2 Meningitis

Patients are randomised to active treatment with IV acyclovir with the possibility of step-down to valacyclovir. If the treating physician prefers, initial IV treatment can be omitted and the patient can be treated with valacyclovir throughout the study period.

Placebo either in IV formulation or as tablets identical to valacyclovir tablets.